You are here

Atacand

AstraZeneca offloads Atacand in Europe for $200M

Biopharma Dive

Wed, 07/25/18 - 03:13 pm

AstraZeneca sells US rights to 4 non-core drugs

Biopharma Dive

Wed, 01/3/18 - 11:07 am

ANI Pharmaceuticals

FDA takes a closer look at possible cancer risks of widely used blood pressure medicines

Star Ledger, NJ

Fri, 07/16/10 - 09:26 am

Bristol-Myers Squibb

AstraZeneca to pay Merck $647M for drug interests

Yahoo/AP

Mon, 03/1/10 - 09:31 am